Health
Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19 – News-Medical.Net
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School…
Reviewed by Emily Henderson, B.Sc.Nov 12 2020
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.
The study, a collaboration between the university’s Department of Psychiatry and…
-
Noosa News23 hours agoQueensland teachers strike for second time this year after rejecting 8 per cent wage rise
-
General23 hours agoVictorian government blocked fire service from pursuing US giant over PFAS contamination
-
Noosa News14 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
General15 hours agoLabor to squeeze public service, sparking warnings of job losses